This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.
ITM and POINT Biopharma Expand Global Supply Agreement for n.c.a. Lutetium-177
ITM Enters Cooperation Agreement with Paul Scherrer Institute (PSI) for Co-Development and Upscaled Manufacturing of Terbium-161 for Theranostic Application in Cancer
Julia Hofmann
Head of Corporate Communications
Phone: +49 89 329 8986 1500